GeneDx Holdings Corp. (WGS) Insider Trading
- $4,263,232.78
- $25,082,538.95
- Sept. 9, 2024
- Kevin Feeley
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 11, 2023 | Insider | 846 | $4.62 | Sell | $3,908.52 | |
| Sept. 5, 2023 | CFO | 269 | $4.38 | Sell | $1,178.22 | |
| Aug. 17, 2023 | Director | 5,000 | $5.10 | Buy | $25,500.00 | |
| July 26, 2023 | Insider | 61 | $7.41 | Sell | $452.01 | |
| July 20, 2023 | Insider | 163 | $7.85 | Sell | $1,279.55 | |
| July 3, 2023 | Insider | 45 | $5.99 | Sell | $269.55 | |
| June 20, 2023 | Insider | 1,549 | $6.37 | Sell | $9,867.13 | |
| June 20, 2023 | CEO | 7,965 | $6.37 | Sell | $50,737.05 | |
| June 20, 2023 | CFO | 2,744 | $6.37 | Sell | $17,479.28 | |
| June 13, 2023 | CFO | 903 | $6.49 | Sell | $5,860.47 | |
| June 12, 2023 | Insider | 828 | $6.49 | Sell | $5,373.72 | |
| June 12, 2023 | CEO | 2,674 | $6.49 | Sell | $17,354.26 | |
| June 2, 2023 | CFO | 263 | $7.00 | Sell | $1,841.00 | |
| May 18, 2023 | Director | 5,000 | $5.90 | Buy | $29,500.00 | |
| May 16, 2023 | CEO | 8,685 | $6.50 | Sell | $56,452.50 | |
| May 16, 2023 | CFO | 1,516 | $6.50 | Sell | $9,854.00 | |
| April 26, 2023 | Insider | 2,015 | $0.29 | Sell | $584.35 | |
| April 20, 2023 | Insider | 5,338 | $0.31 | Sell | $1,654.78 | |
| April 3, 2023 | Insider | 1,731 | $0.34 | Sell | $588.54 | |
| March 10, 2023 | CFO | 31,876 | $0.36 | Sell | $11,475.36 | |
| March 10, 2023 | CEO | 92,644 | $0.36 | Sell | $33,351.84 | |
| March 10, 2023 | Insider | 32,787 | $0.36 | Sell | $11,803.32 |
Insiders are both buying and selling GeneDx Holdings Corp. stock.
The insider traders at GeneDx Holdings Corp. are: Kevin Feeley, Opko Health, Inc., Katherine Stueland, Kareem Saad, Karen Ann White, Casdin Capital, Llc, Richard C Pfenniger Jr, and Jason Ryan
The most active insider trader at GeneDx Holdings Corp. is Kevin Feeley with 17 trades.
Opko Health, Inc. has sold the most GeneDx Holdings Corp. stock with a total value of $25,598,634.15.
Casdin Capital, Llc has bought the most GeneDx Holdings Corp. stock with a total value of $6,203,270.44.
The most recent insider trade for GeneDx Holdings Corp. was on Sept. 9, 2024.
The single biggest insider buy for GeneDx Holdings Corp. was from Casdin Capital, Llc with a total value of $2,082,000.00 on June 3, 2024.
The single biggest insider sell for GeneDx Holdings Corp. was from Opko Health, Inc. with a total value of $3,182,000.00 on Aug. 8, 2024.